Chronic neuropathic pain-like behavior and brain-borne IL-1β

Annals of the New York Academy of Sciences

Volumn 1262, Issue 1, 2012, Pages 101-107

  del Rey, Adriana ^a   Apkarian, A Vania ^b   Martina, Marco ^b   Besedovsky, Hugo O ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic pain; Hippocampus; Interleukin 1; Lateralization

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ARTICLE; BRAIN STEM; CHRONIC PAIN; CYTOKINE PRODUCTION; HIPPOCAMPUS; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALIA; RATTUS;

EID: 84864135575     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06621.x     Document Type: Article

References (56)

1. American Academy of Pain Medicine. 2012. URL: [Accessed on 1 June 2012]
2. Global Industry Analysts. 2011. URL: [Accessed on 1 June 2012].
3. Myers, R.R., W.M. Campana & V.I. Shubayev. 2006. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov. Today 11: 8-20.
4. Pace, M.C. et al. 2006. Neurobiology of pain. J. Cell. Physiol. 209: 8-12.
5. Zimmermann, M. 2001. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 429: 23-37.
6. Bennett, G.J. & Y.K. Xie. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
7. Kim, K.J., Y.W. Yoon & J.M. Chung. 1997. Comparison of three rodent neuropathic pain models. Exp. Brain Res. 113: 200-206.
8. Dinarello, C.A. 2011. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur. J. Immunol. 41: 1203-1217.
9. Ferreira, S.H. et al. 1988. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334: 698-700.
10. Zelenka, M., M. Schafers & C. Sommer. 2005. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 116: 257-263.
11. Sommer, C. & M. Kress. 2004. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 361: 184-187.
12. Ren, K. & R. Torres. 2009. Role of interleukin-1beta during pain and inflammation. Brain Res. Rev. 60: 57-64.
13. Nadeau, S. et al. 2011. Functional recovery after peripheral nerve injury is dependent on the proinflammatory cytokines IL-1beta and TNF: implications for neuropathic pain. J. Neurosci. 31: 12533-12542.
14. Uceyler, N. & C. Sommer. 2008. Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci. Lett. 437: 194-198.
15. DeLeo, J.A., R.W. Colburn & A.J. Rickman. 1997. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759: 50-57.
16. Shamash, S., F. Reichert & S. Rotshenker. 2002. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 22: 3052-3060.
17. Lee, H.L. et al. 2004. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 15: 2807-2811.
18. Rotshenker, S., S. Aamar & V. Barak. 1992. Interleukin-1 activity in lesioned peripheral nerve. J. Neuroimmunol. 39: 75-80.
19. Okamoto, K. et al. 2001. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp. Neurol. 169: 386-391.
20. Kleinschnitz, C. et al. 2005. Contralateral cytokine gene induction after peripheral nerve lesions: dependence on the mode of injury and NMDA receptor signaling. Brain Res. Mol. Brain Res. 136: 23-28.
21. Ruohonen, S. et al. 2002. Contralateral non-operated nerve to transected rat sciatic nerve shows increased expression of IL-1beta, TGF-beta1, TNF-alpha, and IL-10. J. Neuroimmunol. 132: 11-17.
22. Boivin, A. et al. 2007. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci. 27: 12565-12576.
23. Woolf, C.J. & M.W. Salter. 2000. Neuronal plasticity: increasing the gain in pain. Science 288: 1765-1769.
24. Bianchi, M., B. Dib & A.E. Panerai. 1998. Interleukin-1 and nociception in the rat. J. Neurosci. Res. 53: 645-650.
25. Apkarian, A.V. 2008. Pain perception in relation to emotional learning. Curr. Opin. Neurobiol. 18: 464-468.
26. Apkarian, A.V., J.A. Hashmi & M.N. Baliki. 2011. Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain 152: S49-S64.
27. Hori, T. et al. 1998. Pain modulatory actions of cytokines and prostaglandin E2 in the brain. Ann. N.Y. Acad. Sci. 840: 269-281.
28. Apkarian, A.V. et al. 2006. Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain. Neurosci. Lett. 407: 176-181.
29. Apkarian, A.V. et al. 2004. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J. Neurosci. 24: 10410-10415.
30. Grachev, I.D., B.E. Fredrickson & A.V. Apkarian. 2000. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain 89: 7-18.
31. Liu, M.G. & J. Chen. 2009. Roles of the hippocampal formation in pain information processing. Neurosci. Bull. 25: 237-266.
32. Duric, V. & K.E. McCarson. 2006. Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J. Pain 7: 544-555.
33. Terada, M. et al. 2008. Suppression of enriched environment-induced neurogenesis in a rodent model of neuropathic pain. Neurosci. Lett. 440: 314-318.
34. Ren, W.J. et al. 2011. Peripheral nerve injury leads to working memory deficits and dysfunction of the hippocampus by upregulation of TNF-alpha in rodents. Neuropsychopharmacology 36: 979-992.
35. Schneider, H. et al. 1998. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 95: 7778-7783.
36. Avital, A. et al. 2003. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13: 826-834.
37. Depino, A.M. et al. 2004. Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation. Hippocampus 14: 526-535.
38. Yirmiya, R., G. Winocur & I. Goshen. 2002. Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning. Neurobiol. Learn. Mem. 78: 379-389.
39. Uceyler, N., A. Tscharke & C. Sommer. 2008. Early cytokine gene expression in mouse CNS after peripheral nerve lesion. Neurosci. Lett. 436: 259-264.
40. Decosterd, I. & C.J. Woolf. 2000. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87: 149-158.
41. Lovell, J.A. et al. 2000. Strain differences in neuropathic hyperalgesia. Pharmacol. Biochem. Behav. 65: 141-144.
42. Yoon, Y.W. et al. 1999. Different strains and substrains of rats show different levels of neuropathic pain behaviors. Exp. Brain Res. 129: 167-171.
43. del Rey, A. et al. 2011. Chronic neuropathic pain-like behavior correlates with IL-1β expression and disrupts cytokine interactions in the hippocampus. Pain 152: 2827-2835.
44. Al-Amin, H. et al. 2011. Chronic dizocilpine or apomorphine and development of neuropathy in two animal models II: effects on brain cytokines and neurotrophins. Exp. Neurol. 228: 30-40.
45. Gabay, E. et al. 2011. Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. Eur. J. Pain 15: 242-248.
46. Wolf, G. et al. 2003. Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects. Pain 104: 471-480.
47. Wang, Z. et al. 2008. Interleukin-1 beta of Red nucleus involved in the development of allodynia in spared nerve injury rats. Exp. Brain Res. 188: 379-384.
48. Milligan, E.D. et al. 2003. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23: 1026-1040.
49. Besedovsky, H.O. & A. del Rey. 2011. Central and peripheral cytokines mediate immune-brain connectivity. Neurochem. Res. 36: 1-6.
50. Bellinger, F.P., S. Madamba & G.R. Siggins. 1993. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628: 227-234.
51. Katsuki, H. et al. 1990. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181: 323-326.
52. Yirmiya, R. & I. Goshen. 2011. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25: 181-213.
53. Apkarian, A.V. et al. 2004. Chronic pain patients are impaired on an emotional decision-making task. Pain 108: 129-136.
54. Hu, Y. et al. 2010. Amitriptyline rather than lornoxicam ameliorates neuropathic pain-induced deficits in abilities of spatial learning and memory. Eur. J. Anaesthesiol. 27: 162-168.
55. Ji, G. et al. 2010. Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation. J. Neurosci. 30: 5451-5464.
56. Norman, G.J. et al. 2010. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol. Psychiatry 15: 404-414.